Hematological toxicities with Lutathera® for neuroendocrine neoplasms: post-marketing surveillance data from the US-FDA
Endocrine
.
2024 Dec;86(3):1192-1193.
doi: 10.1007/s12020-024-03915-z.
Epub 2024 Jun 7.
Authors
Udhayvir Singh Grewal
1
,
Anuj Thakre
2
Affiliations
1
Division of Hematology, Oncology, Bone and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
[email protected]
.
2
Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
PMID:
38849643
DOI:
10.1007/s12020-024-03915-z
No abstract available
Publication types
Letter